DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,677,048 | -19.9% | 1,713,531 | -0.4% | 3.70% | -16.1% |
| Q2 2023 | $413,059,360 | -4.7% | 1,721,083 | +0.0% | 4.41% | -11.2% |
| Q1 2023 | $433,591,312 | -5.6% | 1,720,329 | -0.6% | 4.97% | -12.6% |
| Q4 2022 | $459,136,444 | +1.9% | 1,729,850 | -0.8% | 5.68% | -3.1% |
| Q3 2022 | $450,568,000 | +1.2% | 1,744,431 | -0.6% | 5.86% | +7.1% |
| Q2 2022 | $445,125,000 | -13.9% | 1,755,783 | -0.4% | 5.47% | +3.1% |
| Q1 2022 | $517,036,000 | -12.0% | 1,762,643 | -1.3% | 5.30% | -1.5% |
| Q4 2021 | $587,517,000 | +7.4% | 1,785,713 | -0.6% | 5.39% | -0.6% |
| Q3 2021 | $547,121,000 | +13.1% | 1,797,140 | -0.3% | 5.42% | +10.5% |
| Q2 2021 | $483,937,000 | +19.2% | 1,803,316 | -0.0% | 4.90% | +9.2% |
| Q1 2021 | $405,897,000 | +0.9% | 1,803,345 | -0.5% | 4.49% | -0.3% |
| Q4 2020 | $402,461,000 | +3.1% | 1,811,747 | -0.1% | 4.50% | -8.0% |
| Q3 2020 | $390,324,000 | +21.0% | 1,812,675 | -0.7% | 4.90% | +10.1% |
| Q2 2020 | $322,654,000 | +26.9% | 1,824,659 | -0.7% | 4.45% | +4.4% |
| Q1 2020 | $254,327,000 | -9.9% | 1,837,490 | -0.1% | 4.26% | +11.8% |
| Q4 2019 | $282,381,000 | +6.3% | 1,839,857 | +0.0% | 3.81% | -1.2% |
| Q3 2019 | $265,629,000 | +0.5% | 1,839,155 | -0.5% | 3.86% | +0.3% |
| Q2 2019 | $264,189,000 | +6.8% | 1,848,515 | -1.3% | 3.85% | +2.3% |
| Q1 2019 | $247,349,000 | +27.1% | 1,873,574 | -0.7% | 3.76% | +6.8% |
| Q4 2018 | $194,555,000 | -4.4% | 1,886,682 | +0.7% | 3.52% | +9.2% |
| Q3 2018 | $203,515,000 | +10.2% | 1,872,956 | +0.1% | 3.22% | +0.6% |
| Q2 2018 | $184,600,000 | +0.5% | 1,870,703 | -0.3% | 3.20% | -4.0% |
| Q1 2018 | $183,730,000 | +5.9% | 1,876,514 | +0.4% | 3.34% | +4.8% |
| Q4 2017 | $173,521,000 | +8.8% | 1,869,433 | +0.5% | 3.19% | +3.4% |
| Q3 2017 | $159,510,000 | +8.2% | 1,859,516 | +2.8% | 3.08% | +5.2% |
| Q2 2017 | $147,367,000 | +3.7% | 1,808,396 | +8.8% | 2.93% | -1.4% |
| Q1 2017 | $142,169,000 | +12.7% | 1,662,217 | +2.6% | 2.97% | +5.7% |
| Q4 2016 | $126,136,000 | +6.7% | 1,620,451 | +7.4% | 2.81% | +4.0% |
| Q3 2016 | $118,248,000 | -21.8% | 1,508,464 | +0.8% | 2.70% | -22.1% |
| Q2 2016 | $151,131,000 | +9.9% | 1,496,341 | +3.2% | 3.47% | +7.1% |
| Q1 2016 | $137,561,000 | +6.6% | 1,450,147 | +4.4% | 3.24% | +1.6% |
| Q4 2015 | $129,009,000 | +20.8% | 1,388,987 | +11.3% | 3.19% | +17.2% |
| Q3 2015 | $106,823,000 | 0.0% | 1,248,076 | 0.0% | 2.72% | 0.0% |
| Q2 2015 | $106,823,000 | +10.9% | 1,248,076 | +10.0% | 2.72% | +12.1% |
| Q1 2015 | $96,337,000 | -50.4% | 1,134,708 | -49.9% | 2.43% | -2.4% |
| Q4 2014 | $194,299,000 | +125.7% | 2,266,942 | +100.1% | 2.49% | +6.9% |
| Q3 2014 | $86,093,000 | -2.9% | 1,133,107 | +0.6% | 2.33% | -3.0% |
| Q2 2014 | $88,698,000 | +3.4% | 1,126,603 | -1.5% | 2.40% | +2.3% |
| Q1 2014 | $85,766,000 | -1.9% | 1,143,543 | +1.0% | 2.34% | -2.7% |
| Q4 2013 | $87,407,000 | +13.2% | 1,132,221 | +1.7% | 2.41% | +2.2% |
| Q3 2013 | $77,209,000 | +13.9% | 1,113,817 | +4.0% | 2.36% | +11.1% |
| Q2 2013 | $67,796,000 | – | 1,071,029 | – | 2.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |